Amgen, Merck, Novo, More Take Cardiovascular Benefits to New Heights at AHA 2025
Data presented at this year’s American Heart Association Scientific Sessions in New Orleans underline rapid advancements in the cardiovascular field.
Amgen, Merck, Novo, More Take Cardiovascular Benefits to New Heights at AHA 2025 Read More »
